HUTCHMED DRC (HCM)
[Press Release] HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress
[Press Release] HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress
Il computer quantistico IQM diventa operativo presso il centro italiano di supercalcolo CINECA, potenziando l’infrastruttura di calcolo e la ricerca nazionali
NowVertical Appoints Andre Garber as Interim CEO of the Company
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress
LCID INVESTOR REMINDER: Lucid Group, Inc. Investors Have Until July 28, 2026 To Seek Lead Plaintiff Role
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Nasdaq-100 Index® June 2026 Quarterly Changes
INVESTOR ALERT: Securities Class Action Filed Against Erasca, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
Extraordinary/ Special General Meeting:
General Announcement: The exchange offer in relation to the S$53.8m Notes due 2026